NP-18-3

About Nanopharmaceutics

Nanopharmaceutics is a clinical-stage biotech focused on enhancing drug delivery through nanoparticle formulations, primarily for BCS Class II and IV small molecules. The company has a pipeline of nine clinical-stage programs across oncology, CNS, metabolic, and infectious disease indications, supported by a leadership team with a long track record in product development and government contracting. While privately held, it operates as a subsidiary of the public entity TRON Group Inc. (OTC: TGRP) and leverages affiliate Alchem Laboratories for discovery capabilities, positioning itself to address significant unmet needs in targeted drug delivery.

Therapeutic Areas

Other CNS Disorders Drugs